MarketInOut Stock Screener Log In | Sign Up

Medicamen Biotech Ltd

Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 10/28/2026 15:29
Medicamen Biotech Ltd stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
Market Capitalization3,436.14 mln
Float8.08 mln

EPS

7.41
Stretched

P / E

34.41
Overvalued

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-1.83
Caution advised

Relative Strength

8 / 100
Severely lagging

Debt / Equity

0.18
Very low leverage

Business Description

Founded in 1993 and headquartered in New Delhi, Medicamen Biotech Limited makes and sells a wide range of medicines both within India and abroad. The company produces tablets, capsules, syrups, oral solutions, and drops that cover many medical needs, including cancer treatment, heart care, diabetes, infections, pain relief, and nutritional supplements. Its portfolio also extends to antibiotics, anti-malarials, and central nervous system treatments, making it a broad-based pharmaceutical business.

Key Fundamentals

EPS7.41
P/E34.41
ROE4.25
RPS160
ROIC3.57
ROA3.14
Interest Cover3.81
EBITDA, mln228
EV / EBITDA20.06
EV / EBIT29.32
Revenue, mln2,026
EV / Revenue2.26

Quote Details

Last 255.00
Change -8.85 (-3.35%)
Open 263.00
Volume 15,449
Turnover 3,939,495
Average Volume 18,932

Financial Ratios

Pre-Tax Profit Margin6
Current Ratio2.55
Price / Book1.49
Price / Tangible Book1.49
Debt / Equity0.18
Price / Sales2.12

Financial Strength

Altman Z-Score4.25
Piotroski F-Score 5 / 9
Beneish M-Score-1.83
Price to Intrinsic Value11.36
Price to Graham Number1.62
Shiller PE Ratio27.87

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -4.42% 26 / 100   
1 Month -19.05% 8 / 100   
2 Months 2.75% 76 / 100   
6 Months 1.37% 65 / 100   
1 Year -19.46% 44 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog